Heron Therapeutics Inc (NASDAQ:HRTX)

12.69
Delayed Data
As of May 21
 +0.29 / +2.34%
Today’s Change
6.51
Today|||52-Week Range
16.49
+26.14%
Year-to-Date

Today’s Trading

Previous close12.40
Today’s open12.51
Day’s range-- - --
Volume191,980
Average volume (3 months)274,076
Market cap$367.4M
Dividend yield--
Data as of 05/21/2015

Growth & Valuation

Earnings growth (last year)+16.08%
Earnings growth (this year)-0.28%
Earnings growth (next 5 years)+64.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.75

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc+0.07+0.47%
IDRAIdera Pharmaceutical...-0.09-2.88%
PGNXProgenics Pharmaceut...-0.02-0.36%
XNPTXenoport Inc+0.08+1.29%
Data as of 05/21/2015

Financials

Last reporting dateMay 8, 2015
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$0.00
Annual profit (last year)-$76.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers